Visceral leishmaniasis in children: A cohort of 120 patients in a metropolitan city of Brazil

Turkish Journal of Pediatrics

Volumn 53, Issue 2, 2011, Pages 154-160

  Rocha, Natália A ^a   Silva Júnior, Geraldo B ^a,b   Oliveira, Michelle J C ^a,b   Abreu, Krasnalhia Lívia S ^a   Franco, Luiz F L G ^a   Silva, Marcos P ^a   Garcia, Ana Valeska V ^a   Daher, Elizabeth F ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF FORTALEZA   (Brazil)

Author keywords

Children; Complications; Kala azar; Mortality; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; MEGLUMINE ANTIMONATE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADOLESCENT; ANOREXIA; ARTICLE; BLEEDING; BRAZIL; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; COHORT ANALYSIS; COUGHING; DIARRHEA; DRUG CHOICE; FEMALE; FEVER; HEPATOMEGALY; HUMAN; INFANT; INFECTION COMPLICATION; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEPSIS; SPLENOMEGALY; VISCERAL LEISHMANIASIS; VOMITING;

ADOLESCENT; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; MALE; URBAN HEALTH;

EID: 80052061388     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
2. Efstratiadis G, Boura E, Giamalis P, et al. Renal involvement in a patient with visceral leishmaniasis. Nephrol Dial Transplant 2006; 21: 235-236.
3. Guerin PJ, Olliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
4. Camargo LB, Langoni H. Impact of leishmaniasis on public health. J Venom Anim Toxins incl. Trop Dis 2006; 12: 527-548.
5. Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5: 763-774.
6. Salgado Filho N, Ferreira TM, Costa JM. Involvement of the renal function in patients with visceral leishmaniasis (kala-azar). Rev Soc Bras Med Trop 2003; 36: 217-221.
7. Correia JB. Epidemiology of visceral leishmaniasis in Pernambuco, north-east of Brazil and the use of a latex agglutination test in urine for its diagnosis [dissertation]. Liverpool: Liverpool School of Tropical Medicine; 1998.
8. Campos Jr D. Características do calazar na criança. Estudo de 75 casos. J Pediatr (Rio J) 1995; 71: 261-265.
9. Badaró R, Jones TC, Lourenço B. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986; 154: 639-649.
10. Albuquerque PL, Silva Junior GB, Freire CC, et al. Urbanization of visceral leishmaniasis (kala-azar) in Fortaleza, Ceará, Brazil. Rev Panam Salud Publica 2009; 26: 330-333.
11. Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2-8.
12. Askenazi DJ, Bunchman TE. Pediatric acute kidney injury: the use of RIFLE criteria. Kidney Int 2007; 71: 963-964.
13. Cerf BJ, Jones TC, Badaro R, et al. Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis 1987; 156: 1030-1032.
14. Queiroz MJ, Alves JG, Correia JB. Visceral leishmaniasis: clinical and epidemiological features of children in an endemic area. J Pediatr (Rio J) 2004; 80: 141-146.
15. Daher EF, Fonseca PP, Gerhard ES, Silva Leitão TM, Silva Júnior GB. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. J Parasitol 2009; 95: 652-655.
16. Boakye DA, Wilson MD, Kweku M. A review of leishmaniasis in West Africa. Ghana Med J 2005; 39: 94-97.
17. Andrade TM, Carvalho EM, Rocha H. Bacterial infectious in patients with visceral leishmaniasis. J Infect Dis 1990; 162: 1354-1359.
18. Alves JG. Calazar. In: Figueira F, Ferreira OS, Alves JG (eds). Pediatria-Instituto Materno Infantil de Pernambuco (2nd ed). Rio de Janeiro: Medsi; 1996: 320.
19. Nasir AM, Al-Nasser MN, Al-Jurayyan NA, et al. The haematological manifestations of visceral leishmaniasis in infancy and childhood. J Trop Pediatr 1995; 41: 143-148.
20. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 year. Clin Infect Dis 1997; 24: 684-703.
21. Berdichevski RH, Luis LB, Crestana L, Manero RC. Amphotericin B-related nephrotoxicity in low-risk patients. Braz J Infect Dis 2006; 10: 94-99.
22. Bagnis CI, Deray G. Amphotericin B nephrotoxicity. Saudi J Kidney Dis Transplant 2002; 13: 481-491.
23. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005; 45: 96-101.
24. Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 2007; 23: 2159-2173.
25. Chan JC, Williams DM, Roth KS. Kidney failure in infants and children. Pediatr Rev 2002; 23: 47-60.
26. Andreoli SP. Acute renal failure. Curr Opin Pediatr 2002; 14: 183-188.
27. Moghal NE, Brocklebank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 1998; 49: 91-95.
28. Bailey D, Phan V, Litalien C, et al. Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med 2007; 8: 29-35.
29. Pathak A, Pien FD, Carvalho L. Amphotericin B use in a community hospital, with special emphasis on side effects. Clin Infect Dis 1998; 26: 334-338.
30. Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 2001; 111: 528-534.
31. Luber AD, Maa L, Lam M, Guglielmo BJ. Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother 1999; 43: 267-271.
32. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL. Epidemic visceral leishmaniasis in Southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 1996; 124: 664-672.